Evolution of the Average Target: Centene Corporation

Evolution of the Target Price: Centene Corporation

Changes in Analyst Recommendations: Centene Corporation

176d5eb11714adb2aed8.88XBkXXIJCpdwUMZUB_JdXVdoqsYLUiT_SU7OvU1Kvs.uYS3oCOPfUACrjRuBS_7MDAc25lcdTH0qVJKdb1ReZi4sfHSHPkdUx7wdw~ab4165176e9f56b327fac6b2a10e71d7
06-08 JPMorgan Adjusts Price Target on Centene to $60 From $52, Maintains Neutral Rating MT
06-04 UnitedHealth, CVS, Cigna Seen Benefiting From Utilization Trends, AI Upside, Morgan Stanley Says MT
06-04 Morgan Stanley Raises Price Target on Centene to $57 From $50, Keeps Equalweight Rating MT
06-04 Morgan Stanley Adjusts Price Target on Centene to $57 From $50, Maintains Equalweight Rating MT
06-01 Truist Raises Price Target on Centene to $71 From $58, Keeps Buy Rating MT
05-27 Oppenheimer Adjusts Centene Price Target to $67 From $58, Maintains Outperform Rating MT
05-26 Barclays Adjusts Price Target on Centene to $75 From $63, Maintains Overweight Rating MT
05-22 UBS Adjusts Price Target on Centene to $61 From $55, Maintains Neutral Rating MT
05-21 BofA Securities Lifts Price Target on Centene to $72 From $60 MT
05-20 Deutsche Bank Upgrades Centene to Buy From Hold, Adjusts PT to $80 From $53 MT
05-20 Mizuho Adjusts Price Target on Centene to $58 From $50, Maintains Neutral Rating MT
05-05 Bernstein Adjusts Price Target on Centene to $68 From $48, Maintains Outperform Rating MT
05-05 JPMorgan Adjusts Price Target on Centene to $52 From $41, Maintains Neutral Rating MT
05-04 U.S. research roundup - Alphabet, Colgate-Palmolive, Welltower RE
05-01 Wells Fargo Adjusts Centene Price Target to $56 From $44 MT
04-29 Morgan Stanley Adjusts Price Target on Centene to $50 From $45, Maintains Equalweight Rating MT
04-29 Mizuho Adjusts Price Target on Centene to $50 From $41, Maintains Neutral Rating MT
04-29 Truist Raises Price Target on Centene to $58 From $49, Keeps Buy Rating MT
04-29 Oppenheimer Adjusts Price Target on Centene to $58 From $45, Maintains Outperform Rating MT
04-29 Deutsche Bank Adjusts Centene Price Target to $53 From $39, Maintains Hold Rating MT
04-29 UBS Adjusts Price Target on Centene to $55 From $42, Maintains Neutral Rating MT
04-29 Barclays Adjusts Centene Price Target to $63 From $54, Maintains Overweight Rating MT
04-29 Jefferies Adjusts Centene Price Target to $48 From $39, Maintains Hold Rating MT
04-29 Goldman Sachs Adjusts Centene Price Target to $40 From $32, Maintains Sell Rating MT
04-29 Cantor Fitzgerald Upgrades Centene to Overweight From Neutral, Adjusts PT to $60 From $41 MT

Consensus Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Objective/dr gap
-3.23%
-0.89%
+3.46%
+16.03%
-20.68%
-5.76%
+26%
-13.72%
+10.47%
Average +1.30%
Weighted average by Cap. +0.32%
See all sector consensus

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
20
Last Close Price
63.40USD
Average target price
61.35USD
Spread / Average Target
-3.23%
High Price Target
80.00USD
Spread / Highest target
+26.18%
Low Price Target
40.00USD
Spread / Lowest Target
-36.91%

Analyst Consensus Detail

Consensus revision (last 18 months)

Analysts covering the company

JPMorgan Chase
Morgan Stanley
Truist Securities
Oppenheimer
Barclays
UBS
BofA Securities
Deutsche Bank Securities
Mizuho Securities
Bernstein
Wells Fargo Securities
Goldman Sachs
Jefferies & Co.
Cantor Fitzgerald
Baird
TD Cowen
Guggenheim
Stephens Inc.
Argus
Wolfe Research
Credit Suisse
Cowen
Loop Capital
BMO Capital
Citigroup
Seaport Global Securities
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
20
Last Close Price
63.40USD
Average target price
61.35USD
Spread / Average Target
-3.23%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. CNC Stock
  4. Consensus Centene Corporation
- 40% : Our Best Subscriber-Only Tools to Spot Tomorrow’s Top Investments!
d
:
:
SEIZE THE OFFER!